|
|
Article: Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
A few months after starting operations, Hamilton Pharmaceuticals Inc. completed its first financing round, raising $11 million to advance its lead compound in neuropsychiatric indications and in-license additional product candidates.
The specialty pharmaceutical company, which opened its corporate headquarters in Washington two months ago, was formed late last year after licensing its first investigational compound, HL-0812, from a foreign pharmaceutical company, said CEO Thomas Chase.
"We saw an extraordinary opportunity," he told BioWorld Today, and "we just couldn't resist starting up this company to work on that product."
...